2N Pharma ApS: Financial statements 2020
CVR: 41169303
Source: annual report 2020, Danish Business Authority
14/02/2020 – 31/12/2020
2N Pharma ApS (CVR 41169303) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 335,884 and a net result of DKK -187,930. Equity in the 2020 report amounted to DKK -147,930. The company had 1 employee in the financial year.
- Gross Profit
- DKK 335,884
- Profit/Loss
- DKK -187,930
- Equity
- DKK -147,930
- Total Assets
- DKK 10,833,560
- Employees
- 1
Official annual report
How creditworthy is 2N Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of February 16, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 2N Pharma ApS.
As of February 14, 2020, Preben Bruun-Nyzell is registered as director of 2N Pharma ApS.
As of February 14, 2020, Josephus Dirk Vestergaard Nieland is registered as director of 2N Pharma ApS.
2N Pharma ApS was founded on February 14, 2020.
About 2N Pharma ApS
2N Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2020. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by 2N Pharma Holding ApS. According to the 2024 annual report, the company had an average of 3 employees. In 2024, the company reported a gross profit of DKK 1,077,483 and a net result of DKK -396,379 compared with DKK -346,799 the year before. Equity in the 2024 report amounted to DKK 10,304,869.